News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,883 Results
Type
Article (86715)
Company Profile (703)
Press Release (763463)
Multimedia
Podcasts (138)
Webinars (17)
Section
Business (232764)
Career Advice (4130)
Deals (39742)
Drug Delivery (129)
Drug Development (91056)
Employer Resources (198)
FDA (18155)
Job Trends (17353)
News (396685)
Policy (39791)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (101)
Alliances (56929)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (184)
Approvals (18103)
Artificial intelligence (366)
Autoimmune disease (34)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (374)
Cancer (2894)
Cardiovascular disease (232)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (33)
Cell therapy (550)
Cervical cancer (23)
Clinical research (73997)
Collaboration (1034)
Company closure (3)
Compensation (649)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (315)
Cystic fibrosis (117)
Data (2859)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (328)
Diagnostics (6958)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (165)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (122)
Earnings (97408)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131224)
Executive appointments (876)
FDA (19748)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (935)
Gene editing (141)
Generative AI (36)
Gene therapy (415)
GLP-1 (894)
Government (5223)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (36)
Infectious disease (3069)
Inflammatory bowel disease (162)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (114)
Interviews (813)
IPO (17882)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10126)
Liver cancer (83)
Lung cancer (412)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (408)
MASH (92)
Medical device (14690)
Medtech (14695)
Mergers & acquisitions (22521)
Metabolic disorders (876)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (37)
Neuroscience (2240)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (46)
Obesity (463)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (111)
Parkinson's disease (188)
Partnered (25)
Patents (293)
Patient recruitment (142)
Peanut (53)
People (65573)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22852)
Phase II (32130)
Phase III (24190)
Pipeline (1599)
Policy (215)
Postmarket research (3552)
Preclinical (10316)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (491)
Real estate (7397)
Recruiting (75)
Regulatory (26997)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (875)
Venture capitalists (51)
Weight loss (315)
Women's health (46)
Worklife (20)
Date
Today (123)
Last 7 days (562)
Last 30 days (2609)
Last 365 days (34828)
2025 (16422)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (50407)
Australia (8863)
California (7439)
Canada (2300)
China (676)
Colorado (319)
Connecticut (335)
Delaware (192)
Europe (115654)
Florida (1099)
Georgia (253)
Hawaii (1)
Idaho (65)
Illinois (708)
India (32)
Indiana (371)
Iowa (16)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1066)
Massachusetts (5678)
Michigan (267)
Minnesota (463)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2074)
New Mexico (31)
New York (2088)
North Carolina (1209)
North Dakota (10)
Northern California (3211)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1591)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2742)
Tennessee (121)
Texas (1117)
United States (28107)
Utah (221)
Virginia (199)
Washington D.C. (79)
Washington State (659)
West Virginia (4)
Wisconsin (82)
There are 850,883 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iLeadBMS Presents Preclinical Data on IL21120033, a First-in-Class ACKR3 Ago-PAM at EULAR 2025
June 16, 2025
·
1 min read
Press Releases
Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
June 16, 2025
·
3 min read
Press Releases
Lung Cancer Patient in Lantern Pharma’s Harmonic Trial Shows Durable Complete Response in Target Cancer Lesions with Survival Continuing for Nearly Two Years
June 16, 2025
·
10 min read
Press Releases
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
June 16, 2025
·
9 min read
Press Releases
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025
June 16, 2025
·
1 min read
Press Releases
Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy
June 16, 2025
·
2 min read
Press Releases
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
June 16, 2025
·
6 min read
Press Releases
X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
June 16, 2025
·
9 min read
Press Releases
VANFLYTA® is Now Approved in Canada Specifically for Adult Patients with Newly Diagnosed FLT3-ITD Positive AML
June 16, 2025
·
7 min read
Press Releases
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
June 16, 2025
·
1 min read
1 of 85,089
Next
